Catalyst Wire Dossier Catalyst Wire Dossier

Rebamipide

rebamipide · Daewoong Pharmaceutical Co. LTD.
Drug timelines are a Plus or Pro feature.

19 regulatory and trial events tracked for Rebamipide, covering 2009-09-21 to 2026-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Rebamipide Versus Diquafosol and Cyclosporine for Perioperative Dry Eye in Cataract Surgery [Phase 4]

See pricing